REQUEST A DEMO
Total
USD $0.00
Search more companies

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. is a national high-tech enterprise located in Jinhua, Zhejiang. The company specializes in the breeding, cultivation, processing, and sales of precious Chinese medicinal materials such as Lingzhi, Tiepishihu, and saffron. Their core products include Shouxiangu brand Lingzhi spore powder (broken wall), Shouxiangu brand broken wall Lingzhi spore powder, Shouxiangu brand broken wall Lingzhi spore powder granules, Shouxiangu brand Tiepifengdou granules, and Shouxiangu brand Tiepifengdou Lingzhi extract. The company is a leader in the research and development of Lingzhi and Tiepishihu technologies, as well as the establishment of industry standards. They have developed ISO international standards for "Traditional Chinese Medicine - Lingzhi" and "Traditional Chinese Medicine - Tiepishihu," which were officially released in December 2018 and February 2019, respectively. The company is also responsible for revising the production standards for Lingzhi spore powder included in the "Zhejiang Province Traditional Chinese Medicine Processing Standards" (2015 edition) as commissioned by the Zhejiang Provincial Drug Administration. The company has been involved in the formulation of the "Chinese Medicinal Dendrobium Standard" and the "Zhejiang Province Local Standard - Pollution-Free Tiepishihu," which have been widely promoted in the industry for many years. These standards have effectively improved the level of standardized cultivation techniques for Tiepishihu in Zhejiang Province and provided technical assurance for high-yield cultivation and product quality control for farmers.

Headquarters
No. 12, Huanglong 3rd Road, Hushan Street, Wuyi County, Jinhua City, Zhejiang Province
Jinhua; Zhejiang; Postal Code: 321200

Contact Details: Purchase the Zhejiang Shouxiangu Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.sxg1909.com

Basic Information
Total Employees:
Purchase the Zhejiang Shouxiangu Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Zhejiang Shouxiangu Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Zhejiang Shouxiangu Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Zhejiang Shouxiangu Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
March 03, 1997
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
28.1%
Purchase this report to view the information.
7.45%
Purchase this report to view the information.
4.81%
Purchase this report to view the information.
2.53%
Purchase this report to view the information.
1.93%
Subsidiaries
Beijing Shouxiangu Health Technology Co., Ltd.
100%
Boyu Smart Health Research Institute, Yuhang District, Hangzhou
100%
Hangzhou Shouxiangu Health Management Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Zhejiang Shouxiangu Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-13.01%
Total operating revenue
-12.63%
Operating profit (EBIT)
-13.86%
Net Profit (Loss) for the Period
-14.85%
Total assets
2.6%
Total equity
8.42%
Operating Profit Margin (ROS)
-0.25%
Net Profit Margin
-0.54%
Return on Equity (ROE)
-1.45%
Debt to Equity Ratio
-7.65%
Quick Ratio
0.42%
Cash Ratio
-0.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?